Molnupiravir reduces hospitalization in at-risk outpatients with symptomatic COVID-19
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Molnupiravir Reduces Hospitalization in At-risk Outpatients With Symptomatic COVID-19." EE+ POEM Archive, John Wiley & Sons, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315562/all/Molnupiravir_reduces_hospitalization_in_at_risk_outpatients_with_symptomatic_COVID_19.
Molnupiravir reduces hospitalization in at-risk outpatients with symptomatic COVID-19. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2024. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315562/all/Molnupiravir_reduces_hospitalization_in_at_risk_outpatients_with_symptomatic_COVID_19. Accessed December 8, 2024.
Molnupiravir reduces hospitalization in at-risk outpatients with symptomatic COVID-19. (2024). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315562/all/Molnupiravir_reduces_hospitalization_in_at_risk_outpatients_with_symptomatic_COVID_19
Molnupiravir Reduces Hospitalization in At-risk Outpatients With Symptomatic COVID-19 [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315562/all/Molnupiravir_reduces_hospitalization_in_at_risk_outpatients_with_symptomatic_COVID_19.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Molnupiravir reduces hospitalization in at-risk outpatients with symptomatic COVID-19
ID - 1315562
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315562/all/Molnupiravir_reduces_hospitalization_in_at_risk_outpatients_with_symptomatic_COVID_19
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -